ADC Therapeutics ADCT Q1 2025 earnings
Reported May 14, 2025 · Before market open
Revenue$23.0MBeat by $5.5M
EPS-$0.36Beat by $0.02
Revenue estimate$17.5M
EPS estimate-$0.38
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$18.9M
EPS estimate-$0.19
Versus estimates
Revenue
Diluted EPS
Ask the moment ADC Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did ADC Therapeutics report Q1 2025 earnings?
- ADC Therapeutics (ADCT) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were ADC Therapeutics's Q1 2025 revenue and EPS?
- ADC Therapeutics reported revenue of $23.0M and eps of $-0.36 for Q1 2025.
- Did ADC Therapeutics beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $17.5M by $5.5M. EPS beat the consensus estimate of $-0.38 by $0.02.
- How did ADC Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 27.6% from $18.1M a year earlier and eps grew 35.7% from $-0.56.
- Where can I find ADC Therapeutics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001628280-25-025481) directly on SEC EDGAR. The filing index links above go to sec.gov.